叮噹健康科技集團有限公司（09886.HK）于2025年12月17日发布翌日披露报表，披露当日通过香港联交所场内回购95,000股普通股，回购价格介乎每股1.05港元至1.07港元，涉资合计约100,947港元。
本次回购股份尚未注销，叠加之前已购回但未注销股份后，暂未对公司现有已发行股本总数1,319,472,897股产生影响。根据回购授权信息，公司可于2025年5月28日通过的决议下购回最多131,947,289股。截至目前累计回购股份数约为6,635,000股，占授权通过当日已发行股份总数的约0.502852%。
公司在公告中确认，回购过程已遵守香港联交所上市规则及相关法律法规。上述翌日披露报表由联席公司秘書林晓波签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.